Clinical Trial

Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting

Name: Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting — clinical trial record (NCT07692451)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is aimed to evaluate the efficacy and safety of Fosrolapitant and Palonosetron for Antibody-drug conjugate-induced nausea and vomiting

Trial Details

NCT Number	NCT07692451
Lead Sponsor	Peking University Cancer Hospital & Institute
Conditions	Nausea and Vomiting Induced by Antibody-drug Conjugates (ADCs)
Enrollment	124 participants
Start Date	2026-07-15
Primary Completion	2027-07-15 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-09